Defibrotide prophylaxis of Veno-Occlusive disease in children with High-Risk Neuroblastoma treated with Busulfan-Melphalan High-Dose Chemotherapy and Autologous Stem Cell Transplantation

被引：0
|
作者：
Pasqualini, C. [1 ]
Cros, G. [1 ]
Dufour, C. [1 ]
Abbou, S. [1 ]
Dourthe, M. -E. [1 ]
Rigaud, C. [1 ]
Valteau-Couanet, D. [1 ]
机构：
[1] Gustave Roussy Canc Campus, Pediat & Adolescent Oncol, Villejuif, France
来源：
BONE MARROW TRANSPLANTATION | 2016年 / 51卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
P280
引用
收藏
页码：S260 / S260
页数：1
相关论文
共 50 条
  • [41] The Efficacy of High-Dose Chemotherapy and Autologous Stem Cell Transplantation for High-Risk Osteosarcoma
    Sakiyama, Hideki
    Hamada, Satoru
    Yagi, Takeshi
    Miyamoto, Jiro
    Oshiro, Tokiko
    Uehara, Taichi
    Kiyuna, Shinobu
    Tome, Yasunori
    Maehara, Hiroki
    Matsuda, Takehiro
    Higa, Takeshi
    Hyakuna, Nobuyuki
    Nakanishi, Koichi
    PEDIATRIC BLOOD & CANCER, 2019, 66 : S60 - S60
  • [42] High-dose chemotherapy and autologous blood stem cell transplantation in children with metastatic neuroblastoma
    Kai, T
    Ishii, E
    Matsuzaki, A
    Inaba, S
    Suita, S
    Ueda, K
    ACTA PAEDIATRICA JAPONICA, 1997, 39 (01): : 54 - 60
  • [43] Hepatic veno-occlusive disease (VOD) with complete occlusion of liver venules after tandem autologous stem cell transplantation -: successful treatment with high-dose methylprednisolone and defibrotide
    Sayer, HG
    Will, U
    Schilling, K
    Vogt, T
    Wollina, K
    Höffken, K
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2002, 128 (03) : 148 - 152
  • [44] Autologous stem cell transplantation following high-dose chemotherapy in children with high-risk neuroblastoma: Practicality in resource-limited countries
    Lau, Sie Chong Doris
    Unni, Mohamed Najib Mohamed
    Teh, Kok Hoi
    Aziz, Mimi Azura
    Muda, Zulaiha
    Thomas, Shoba Anne
    Quah, Shiao Wei
    Ibrahim, Hishamshah
    Othman, Ida Shahnaz
    PEDIATRIC BLOOD & CANCER, 2020, 67 (05)
  • [45] Clinical results of a new dosing strategy of IV busulfan as part of bumel high-dose chemotherapy followed by autologous stem cel transplantation in children with high-risk solid tumors: Reduced regimen-related toxicity and veno-occlusive disease
    Valteau-Couanet, D.
    Gentet, J. C.
    Vassal, G.
    Doz, F.
    Paillard, C.
    Corradini, N.
    Frappaz, D.
    Hartmann, O.
    Cadic, V.
    Zouabi, H.
    Michel, G.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 187 - 187
  • [46] Hepatic veno-occlusive disease (VOD) with complete occlusion of liver venules after tandem autologous stem cell transplantation – successful treatment with high-dose methylprednisolone and defibrotide
    H. Sayer
    U. Will
    K. Schilling
    T. Vogt
    K. Wollina
    K. Höffken
    Journal of Cancer Research and Clinical Oncology, 2002, 128 : 148 - 152
  • [47] Comparison of Melphalan Combined with Treosulfan or Busulfan as High-Dose Chemotherapy before Autologous Stem Cell Transplantation in AML
    Gurevich, Ekaterina
    Hayoz, Michael
    Aebi, Yolanda
    Largiader, Carlo R.
    Mansouri Taleghani, Behrouz
    Bacher, Ulrike
    Pabst, Thomas
    CANCERS, 2022, 14 (04)
  • [48] Hepatic veno-occlusive disease after tandem autologous stem cell transplantation conditioned by melphalan
    Sana Intidhar Labidi
    Catherine Sebban
    Hervé Ghesquières
    Emmanuele Virelizier Nicolas
    Pierre Biron
    International Journal of Hematology, 2008, 88 : 291 - 293
  • [49] Chemotherapy-induced Nausea and Vomiting Prophylaxis in High-dose Melphalan and Autologous Stem Cell Transplantation
    Tendas, Andrea
    Marchesi, Francesco
    Annibali, Ombretta
    Saltarelli, Debora
    Niscola, Pasquale
    Perrotti, Alessio Pio
    Arcese, William
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 (02): : 161 - 162
  • [50] Hepatic veno-occlusive disease after tandem autologous stem cell transplantation conditioned by melphalan
    Labidi, Sana Intidhar
    Sebban, Catherine
    Ghesquieres, Herve
    Nicolas, Emmanuele Virelizier
    Biron, Pierre
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2008, 88 (03) : 291 - 293
12345